All China Stocks -All Information About China Stocks Traded In U.S. Stock Markets

AllChinaStocks

Biostar Pharmaceuticals, Inc. (BSPM), 2017-08-18 4:35:46 PM

 

1.30 +0.06 (+4.84%)

8/18/2017  3:38pm

Open:

1.24

Pre close:

1.24

High:

1.42

Low:

1.24

Volume:

19,548

Market Cap:

3.46M

Overall  

    **   

What's this
Target Six months: 1.65     One year: 1.81
Support Support1: 1.20    Support2:
Resistance Resistance1: 1.42    Resistance2: 1.55 
Pivot 1.35 
Moving Averages

MA(5): 1.33     MA(20): 1.38

MA(100): 1.65     MA(250): 2.47

MACD MACD(12,26): -0.05     Signal(12,26,9): -0.04
Stochastic Oscillator %K(14,3): 28.57     %D(3): 39.15
RSI RSI(14): 41.93

Financials: 

EPS

-2.550

EPS Est. Current Year

0.600

EPS Est. Next Quarter

EPS Est. Next Year

Forward EPS

1.#IO

Book Value (p.s.)

13.720

PEG Ratio

Profit Margin

Operating Margin

-245.25

Return on Assets (ttm)

-5.3

Return on Equity (ttm)

-15.2

Qtrly Rev. Growth

Gross Profit (p.s.)

0.344

Sales Per Share

EBITDA (p.s.)

-1.038

Qtrly Earnings Growth

Operating Cash Flow (M)

4.89

Levered Free Cash Flow (M)

6.90

Statistics

Shares Out. (M)

2.66

Shares Float (M)

2.22

% Held by Insiders

% Held by Institutions

Shares Short (K)

299

SharesShort PriorMonth (K)

289

Valuation

P/E

-0.51

P/E Growth Ratio

0.05

P/BV

0.09

P/S

5239393.50

P/CF

0.71

Dividend Yield

Stock Price History

52-Week High

7.06

52-Week Change (%)

52-Week Low

1.20

-68.0

* Strong Sell ** Sell *** Neutral **** Buy ***** Strong Buy

 

Symbol:

BSPM

Company Name:

Biostar Pharmaceuticals, Inc.

IPO Year:

n/a

Sector

Health Care

Industry:

Major Pharmaceuticals

Headline News

Fri, 19 May 2017 20:30:00 +0000

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017

XIANYANG, China, May 19, 2017 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health ...

Thu, 13 Apr 2017 20:00:00 +0000

Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2016

XIANYANG, China, April 13, 2017 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and ...

Mon, 21 Nov 2016 21:30:00 +0000

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended September 30, 2016

XIANYANG, China, Nov. 21, 2016 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and ...

Tue, 18 Oct 2016 20:30:00 +0000

Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing

XIANYANG, China, Oct. 18, 2016 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (BSPM) ("Biostar"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that it completed the sale of 425,000 shares of common stock at the price of $4.50 per share, and warrants to purchase 212,500 shares of common stock to institutional investors for gross proceeds of approximately $1.91 million. Biostar plans to use the net proceeds of this offering for working capital and general corporate purposes. A prospectus supplement relating to the offering has been filed by Biostar with the SEC.

Wed, 12 Oct 2016 13:18:00 +0000

Biostar Announces Execution of Agreement for $1.91 Million Registered Direct Offering of Shares of Common Stock and Warrants

XIANYANG, China, Oct. 12, 2016 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that it entered into a securities purchase agreement (the "Securities Purchase Agreement") with certain institutional investors for the sale of 425,000 shares of common stock in a registered direct offering at the price of $4.50 per share. Gross proceeds of the offering, before deducting placement agent fees and other estimated offering expenses payable by the Company, are expected to be approximately $1.91 million.  The net proceeds from this offering will be used for working capital and other general corporate purposes. The securities are being offered through a prospectus supplement pursuant to the Company's effective shelf registration statement and base prospectus.

All China Stocks -All Information About China Stocks Traded In U.S. Stock Markets

All China Stocks dedicates to providing information about China stocks traded in U.S. stock markets, includes: markets headline news, Chinese stocks headline news, Chinese stocks to watch, Chinese stock real time quotes, Chinese stock company profiles and annual reports, objective Chinese stock research and analysis.

©2006 AllChinaStocks.com  Home  Stock Quotes  Stock Picks  Stock Symbols  Allindianstocks  Stoxline  Contact us